Next-Generation OAB Neuromodulation: The Surgery-Free Vivally® System Is Here!_OnDemand-Recording_Next-Generation OAB Neuromodulation: The Surgery-Free Vivally® System Is Here!

Recording_Next-Generation OAB Neuromodulation: The Surgery-Free Vivally® System Is Here!

Video Transcription

Video Summary

The August Industry Webinar featured a discussion on the surgery-free Vivali system for treating overactive bladder (OAB) through neuromodulation. The panel included prominent medical professionals and Jill Schiaparelli, CEO of Evasion Medical. The Vivali system, which aims to be less invasive than traditional methods, provides a non-surgical, EMG-monitored solution for patients suffering from OAB. The session highlighted that neuromodulation often requires invasive procedures, but the Vivali system eliminates the need for surgery, offering a more accessible treatment. The system is suitable for various patients, including those who are drug-naive, drug-stable, or drug-refractory. Initial studies show the system's efficacy is comparable to other advanced OAB therapies like Botox and sacral nerve stimulation. The panel also discussed the system's user-friendly design, ease of use, and device safety. With a new insurance billing code, Vivali is designed to be cost-effective for patients, offering an innovative treatment option in the OAB care pathway. The session concluded with various questions addressing patient demographics, insurance coverage, and implementation in medical practice.

Keywords

Vivali system

overactive bladder

neuromodulation

surgery-free

EMG-monitored

Evasion Medical

drug-refractory

cost-effective

insurance billing